Gritstone Oncology is a company that provides Medicine, Health care, Pharmacy and Therapeutics and more. Gritstone Oncology is headquartered in United States California. Gritstone Oncology was founded in 2015. and was founded by Andrew Allen, Mark Cobbold. Gritstone Oncology has a total of 168 patents and 2 literature
Neoantigen-Based Personalized Cancer Therapeutic Vaccines
[+n]
Genomics Partnering Terms and Agreements
Neoantigen Targeted Therapies Market
RNAi Therapeutics Markets
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for Gritstone Oncology
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for Gritstone Oncology
Sign up to view the full data
Free Trial Now
Download
Gritstone Oncology Frequently Asked Questions
What is Gritstone Oncology's industry?
Gritstone Oncology is in the industry of:Pharmaceutical and Medicine ManufacturingResearch and Development in the Physical, Engineering, and Life Sciences
What technical fields has Gritstone Oncology researched?
Gritstone Oncology is a clinical-stage biotech company developing tumor-specific cancer immunotherapies to fight multiple cancer types. Its approach seeks...